Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 7, 2024 10:30 AM 2 min read

Jamie Dimon: Internet Bubble Was 'Hype,' Artificial Intelligence Is 'Real'

by Adam Eckert Benzinga Editor
Follow
JPM Logo
JPMJPMorgan Chase & Co
$301.000.08%
Overview

JPMorgan Chase & Co (NYSE: JPM) CEO Jamie Dimon sees a future in which AI benefits nearly all aspects of people’s lives and even allows individuals to live longer.

What To Know: In a CNBC interview at JPMorgan's Global High Yield & Leveraged Finance conference in February, Dimon disputed the notion that AI excitement is just "hype."

"This is not hype. This is real. So, you know, when we had the internet bubble the first time around… that was hype. This is not hype, it's real," Dimon said.

Despite companies across the globe racing to implement AI, some observers believe it's a fad. Dimon is not in that camp. Companies are deploying AI at different speeds and the technology is only going to improve, he said.

"It's not hype. This will be for the rest of your life… you're going to find different ways to use it," Dimon said.

Check This Out: Jamie Dimon Is ‘Desperate’ for AI On His Phone, Expands JPMorgan AI Adoption To All Staff

Dimon has long been a supporter of AI advancement. Last year, he said AI was "critical" to JPMorgan's future success. The 68-year-old CEO also suggested that the upside potential of AI was "limitless."

AI will be used across numerous fields, but one of the most exciting is in healthcare, the JPMorgan CEO said.

"It will save lives. It may invent cancer cures because it can do things that the human mind simply cannot do," Dimon said.

The JPMorgan chief explained that AI will be able to combine several data points about your personal background and medical history and then use that data to predict and determine medical conditions.

AI technology can help invent drugs that can cure those conditions and even prevent them from ever happening in the first place, he said: "So I'm a big optimist about AI."

Read Next: 

  • Meta Joins Big Tech’s Shift To Nuclear Power For AI Ambitions

Benzinga file photo by Dustin Blitchok. Some elements of this story were previously reported by Benzinga and it has been updated.

Benzinga file Photo by Dustin Blitchok.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
NewsTechGeneralAIartificial intelligencebanksICYMIJamie DimonKeyProj

Dimon told CNBC earlier this year that JPMorgan had about 200 people designated for AI research, collecting data on large language models (LLMs) and figuring out different ways LLMs can be used. As of March, the company had expanded AI adoption to its entire staff and now reportedly aims to have personal AI assistants for employees in 2025.

JPM Logo
JPMJPMorgan Chase & Co
$301.000.08%
Overview
Comments
Loading...